Latest News

Filters close
Released: 6-May-2021 7:00 AM EDT
ARVO Foundation Announces Winner of Ludwig von Sallmann Clinician-Scientist Award
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Ludwig von Sallmann Clinician-Scientist Award. The award, which recognizes Ludwig von Sallmann, MD, honors awardees with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Sai Chavala, MD, of Texas Christian University (TCU) and The University of Northern Texas Health Science Center (UNTHSC) School of Medicine in Fort Worth, Texas.

Released: 6-May-2021 7:00 AM EDT
ARVO Foundation Announces Winner of Oberdorfer Award in Low Vision Research
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Oberdorfer Award in Low Vision Research. The award, which honors Michael D. Oberdorfer, PhD, recognizes a recipient with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Caroline Klaver, MD, PhD of Erasmus Medical Center, Radboud University Medical Center, and the Institute of Molecular and Clinical Ophthalmology Basel (IOB).

30-Apr-2021 11:40 AM EDT
New study highlights impact of inherited retinal diseases on United States and Canada
Association for Research in Vision and Ophthalmology (ARVO)

Data being presented at the 2021 virtual meeting of the Association for Research in Vision and Ophthalmology (ARVO) highlights the significant impact of inherited retinal diseases (IRD) in the United States and Canada.

30-Apr-2021 10:00 AM EDT
New research suggests lenses age differently in males and females
Association for Research in Vision and Ophthalmology (ARVO)

New research out of the University of Delaware has identified age- and sex-dependent changes in gene expression, highlighting differences between how male and female lenses age. The results will be presented at the virtual 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

30-Apr-2021 7:00 AM EDT
New sequencing technology to increase the diagnostic accuracy for ABCA4 related-disease
Association for Research in Vision and Ophthalmology (ARVO)

New research being presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) unveils an Oxford Nanopore long-range sequencing assay as a novel, low-cost approach for phasing biallelic mutations in the ABCA4 gene, which is responsible for a range of inherited blinding retinal diseases.

30-Apr-2021 7:00 AM EDT
Low macular pigment levels may be novel risk factor for glaucoma among older women
Association for Research in Vision and Ophthalmology (ARVO)

New research out of the University of Wisconsin-Madison, identified an inverse reaction between macular pigment levels and open-angle glaucoma in a 15-year follow-up cohort of older women participating in National Eye Institute (NEI) R01-funded Carotenoids in Age-Related Eye Disease Study 2 (CAREDS2) (2016 - 2019). The research is being presented at 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), which is being hosted virtually.

30-Apr-2021 7:00 AM EDT
Ocular tissue can be infected by SARS CoV-2
Association for Research in Vision and Ophthalmology (ARVO)

Research being presented at the virtual 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) confirms that the SARS-CoV-2 can infect ocular tissue, especially of those with diabetes, and that wearing protective eyewear could reduce transmission of COVID-19.

30-Apr-2021 7:00 AM EDT
Sleep-regulating systems impaired by glaucoma
Association for Research in Vision and Ophthalmology (ARVO)

A new study being presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) points to the cause of high incidence of sleep disorders in patients with glaucoma.

30-Apr-2021 7:00 AM EDT
Novel eyedrop is promising wet AMD treatment
Association for Research in Vision and Ophthalmology (ARVO)

New research has resulted in a new potential therapeutic option for vascular endothelial growth factor (VEGF) after being demonstrated on a mouse model. The results are being presented during the 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), being hosted virtually this year.

30-Apr-2021 7:00 AM EDT
New eyedrop formula can decrease pain and increase tear production in severe dry eye
Association for Research in Vision and Ophthalmology (ARVO)

Gabapentin eye drops can decrease eye pain and stimulate lacrimal secretion, making it an ideal treatment for severe dry eye new research shows. The study will be presented at the 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), being held virtually this year.

30-Apr-2021 7:00 AM EDT
Uveitis and scleritis patients at higher risk of developing age-related macular degeneration
Association for Research in Vision and Ophthalmology (ARVO)

A study has found that patients who had uveitis or scleritis — two types of eye inflammation — were more likely to develop age-related macular degeneration (AMD) as well. This finding — presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) — supports current evidence that AMD develops in the presence of abnormal inflammation of the eye.

30-Apr-2021 7:00 AM EDT
Many diabetic patients go unscreened for diabetic retinopathy in urban centers
Association for Research in Vision and Ophthalmology (ARVO)

New research results out of the University of Toronto indicate that one third of patients with diabetes in an urban center in Canada have not been screened for diabetic retinopathy (DR), and further, that of all patients with diabetes, young adults, immigrants and those not under the care of a family physician are at highest risk of not being screened. The study is being presented at the virtual 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

30-Apr-2021 7:00 AM EDT
COVID-19 pandemic and associated mitigation measures disproportionately impact those with vision loss
Association for Research in Vision and Ophthalmology (ARVO)

A cross sectional study assessing the impact of the pandemic on adults with and without visual or hearing loss has shown that individuals with visual loss may face increased disruption of their daily activities stemming from the pandemic and related mitigation measures, including access to healthcare, transportation, and information. This study out of the University of Michigan Medical School is being presented this week at the virtual 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

30-Apr-2021 7:00 AM EDT
Macular rod and cone photoreceptor structure may impact efficacy of therapeutic approaches
Association for Research in Vision and Ophthalmology (ARVO)

New research suggests patients with congenital cone dysfunction may also experience abnormalities with their rod distribution, potentially impacting efficacy of therapeutic approaches for inherited cone disorders. The study presented this week at the 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) — being hosted virtually — used high-resolution imaging to assess cone and rod structure in patients who lack normal function in two of the three cone types.

30-Apr-2021 7:00 AM EDT
Retinal changes recorded in rodent models of Alzheimer’s disease
Association for Research in Vision and Ophthalmology (ARVO)

ew research shows retinal cell types are vulnerable to Alzheimer’s pathology, suggesting retinal function may be useful in predicting and diagnosing changes in the brain with Alzheimer’s disease. This study will be presented during the 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), being held virtually this year.

30-Apr-2021 7:00 AM EDT
New connection discovered between gut microbiome and eye health
Association for Research in Vision and Ophthalmology (ARVO)

Preliminary research suggests possible application of manipulated gut bacteria may have therapeutic implications in treating age-related macular degeneration (AMD). The early model system is being presented at the 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), being hosted virtually this year.

30-Apr-2021 7:00 AM EDT
Port Delivery System with ranibizumab (PDS) implant may revolutionize anti-VEGF therapy delivery
Association for Research in Vision and Ophthalmology (ARVO)

New research being presented at the virtual 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) demonstrates a novel refillable implant dubbed the Port Delivery System with ranibizumab (PDS) can continuously release the anti-VEGF drug ranibizumab—a proven therapy—into the eye(s) of patients with neovascular age-related macular degeneration (nAMD). PDS is currently an investigational therapy being developed by Genentech, a member of the Roche Group, and is not yet approved by the U.S. Food and Drug Administration

30-Apr-2021 7:00 AM EDT
A new retina atlas of gene expressions will allow for powerful user-led analysis
Association for Research in Vision and Ophthalmology (ARVO)

A new online database will allow researchers to look up gene expression by retina cell type across loads of different studies, three organisms, and multiple developmental stages. PLatform for Analysis of scEiad (PLAE) will premiere at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO).

30-Apr-2021 7:00 AM EDT
Artificial intelligence allows for improved assessment of optic nerve cupping in glaucoma
Association for Research in Vision and Ophthalmology (ARVO)

A study being presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) clarifies and further confirms the relationship between optic nerve cupping and glaucoma using unsupervised artificial intelligence (AI) techniques, unveiling component patterns.

30-Apr-2021 7:00 AM EDT
Adverse environments shown to trigger ocular surface diseases in transplant wards
Association for Research in Vision and Ophthalmology (ARVO)

New research being presented at the virtual 2021 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO) demonstrates that adverse environments is possibly an avoidable risk factor for ocular graft-versus-host-disease (oGVHD), a rapidly progressing, sight-threatening condition of the eye following allogeneic hematopoetic stem cell transplantation (aSCT).

Released: 22-Jan-2021 10:00 AM EST
ARVO Foundation Announces 2021 Pfizer Ophthalmics Carl Camras Translational Research Award Recipient
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Pfizer Ophthalmics Carl Camras Translational Research Award. The award, funded by Pfizer Ophthalmics through the ARVO Foundation, honors Dr. Carl Camras, who is highly respected for his work as a glaucoma specialist and a research scientist, by annually awarding up to three $12,000 awards to young investigators working in areas of translational research. The 2021 awardee is Alex Huang, MD, PhD of the Doheny Eye Institute and University of California in Los Angeles.

Released: 21-Jan-2021 12:00 PM EST
ARVO Foundation Announces 2021 Mallinckrodt Uveitis Research Fellowship Recipient
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals. The award, funded through the ARVO Foundation, supports an early career investigator with a one-year grant of $45,000 to study an aspect of uveitis or other inflammatory conditions of the eye. The 2021 awardee is Shilpa Kodati, MD of the National Eye Institute (NEI) at the National Institutes of Health (NIH).

Released: 19-Jan-2021 12:00 PM EST
ARVO Foundation Announces Winner of Dr. David L. Epstein Award
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Dr. David L. Epstein Award. Jamie Craig, MBBS, FRANZCO, DPhil and Owen Siggs, MD, DPhil, are the recipients of the $100,000 award which is funded through the ARVO Foundation.

Released: 13-Jan-2021 9:00 AM EST
ARVO Foundation Announces Winners of Roche Collaborative Research Fellowship
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the 2021 recipients of the Roche Collaborative Research Fellowships. Wanjiku Mathenge MBChB, MMed, MSc, PhD, Sudhir H Ranganath, PhD, and Pablo Federico Barcelona, PhD, are the recipients of the fellowships that are generously funded by F. Hoffmann-La Roche Ltd., through the ARVO Foundation.

Released: 12-Jan-2021 9:00 AM EST
ARVO Foundation Announces Winners of the Lewis Rudin Glaucoma Prize
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipients of the Lewis Rudin Glaucoma Prize. The award, funded by the May and Samuel Rudin Family Foundation with support of his brother Jack Rudin via the ARVO Foundation, provides a $30,000 award in recognition of an outstanding scholarly article on glaucoma published in a peer-reviewed journal during the previous calendar year. The 2020 recipients are Iqbal Ahmad Ph.D. and Pooja Teotia, PhD, of the University of Nebraska in Omaha, Neb.

Released: 11-Jan-2021 9:00 AM EST
ARVO Foundation Announces Recipients of Genentech AMD Research Fellowships
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2021 Genentech Age-Related Macular Degeneration (AMD) Research Fellowships. The two recipients will each receive $40,000 to support research focused on an aspect of AMD. The 2021 recipients are Yi-Rong Peng, PhD and Kevin J. McHugh, PhD.

Released: 5-Jan-2021 11:05 AM EST
ARVO Foundation Announces 2021 Bert M. Glaser, MD Award for Innovative Retina Research Recipient
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced Yohei Tomita, MD, PhD, has received the 2021 Bert M. Glaser, MD Award for Innovative Research in Retina, which recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition. Tomita is recognized with this award for his retinal translational research, with a focus on diabetic retinopathy (DR) and age-related macular degeneration (AMD).

Released: 24-Nov-2020 10:00 AM EST
ARVO Foundation Announces Recipient of Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipient of the inaugural 2021 Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists. The early-career URM investigator recipient will receive a two-year grant totaling $100,000 to promote the generation of promising preliminary research results. The 2021 recipient is Elizabeth Zuniga-Sanchez, PhD of Baylor College of Medicine in Houston, Texas.

Released: 16-Nov-2020 10:00 AM EST
ARVO Announces Winners of New Advocacy Awards
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the inaugural 2020 Advocacy Awards. The recipient of the Achievements in Eye and Vision Advocacy Award is João M. Furtado, MD, PhD of the Ribeirão Preto Medical School, University of São Paulo. The recipient of the Emerging Advocate Award is Jarrod C. Harman of Louisiana State University Health Sciences Center (LSUHSC).

Released: 24-Jun-2020 12:20 PM EDT
ARVO and ARVO Foundation Awards Nominations Opening July 1
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) and ARVO Foundation for Eye Research announce the opening of nominations for their respective awards, including three new awards— the Genentech Career Development Award for Underrepresented Minority Emerging Vision Scientists, the Achievements in Eye and Vision Advocacy Award, and the Emerging Advocate Award—on July 1, 2020.

Released: 24-Jun-2020 9:50 AM EDT
Dry Eye Awareness Month 2020 Focuses On How Lifestyle Changes During the COVID-19 Pandemic Can Affect Vision
Association for Research in Vision and Ophthalmology (ARVO)

On July 8, the Alliance for Eye and Vision Research (AEVR) in conjunction with the Tear Film & Ocular Surface Society (TFOS) will host the Fifth Annual Dry Eye Awareness Month Congressional Briefing entitled How Lifestyle Changes During the COVID-19 Pandemic Can Affect Vision.

Released: 16-Jan-2020 2:05 PM EST
ARVO Foundation Announces New Genentech Career Development Award for Underrepresented Minorities
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the launch of a new career development program aimed to provide early-career underrepresented minority (URM) scientists the opportunity to explore novel and innovative ideas through a two-year $100,000 grant.

Released: 14-Nov-2019 2:55 PM EST
ARVO and EBAA Announce EyeFind Research Grants
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) and the Eye Bank Association of America (EBAA) today announced a new grant program that will provide financial support to researchers seeking to use human eye tissue in their work.

Released: 25-Jun-2019 8:00 AM EDT
Outdoor Exercise Reduces Progression of Common Vision Issue in Children
Association for Research in Vision and Ophthalmology (ARVO)

New research suggests that adding 30 minutes of daily outdoor activity reduces the progression of nearsightedness, called myopia, in children if the activity is continued. The study, conducted by researchers in Beijing, China, is published in the May 2019 issue of Translational Vision Science & Technology (TVST).

Released: 12-Jun-2019 6:05 AM EDT
Vision Community Dry Eye Awareness Month 2019 Activities Include Congressional Briefing and Screening
Association for Research in Vision and Ophthalmology (ARVO)

Dry eye disease is a global problem affecting more than 30 million people in the United States alone. The Alliance for Eye and Vision Research, in conjunction with Tear Film & Ocular Surface Society, will hold a Congressional Briefing and Screening entitled Ongoing Impact of TFOS DEWS II™ on Dry Eye Clinical Practice & Research, on Capitol Hill, July 10. The Briefing features a panel of experts who participated in the development of the Report speaking about its impact on clinical practice and research.

Released: 2-Apr-2019 2:00 PM EDT
ARVO Foundation Announces New Mallinckrodt Uveitis Research Fellowship
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) today announced the launch of a new fellowship for early-career researchers. The Mallinckrodt Uveitis Research Fellowship, generously funded by Mallinckrodt Pharmaceuticals, will support early career investigators with a one-year grant of $45,000 in their endeavor to investigate the impetus of uveitis or other inflammatory conditions in innovative ways.

Released: 13-Jul-2018 10:00 AM EDT
Eye Summit Puts Focus on Saving Vision in Premature Infants
Association for Research in Vision and Ophthalmology (ARVO)

Thanks to technology discovered through federally funded research, doctors are helping babies born early see better. Cynthia A. Toth, MD of Duke Eye Center will join other vision experts and researchers from around the country at the 2018 Focus on Eye Health National Summit to share the story of the technology used in neonatal intensive care units (NICU) around the country.

Released: 10-Jul-2018 2:00 PM EDT
International Conference Brings Together World Leaders in Eye Cancer
Association for Research in Vision and Ophthalmology (ARVO)

The world’s leading ocular oncology scientists and clinicians are meeting this summer to discuss the latest research and treatment developments in eye cancer. The Ocular Oncogenesis and Oncology Conference (OOO) will be held by the Association for Research in Vision and Ophthalmology (ARV0) in partnership with the Champalimaud Foundation, July 18 – 21 at the Champalimaud Centre for the Unknown in Lisbon, Portugal

Released: 30-May-2018 12:05 PM EDT
Fliesler begins term as ARVO president
Association for Research in Vision and Ophthalmology (ARVO)

Steven J. Fliesler, PhD, FARVO, of the State University of New York-Buffalo and VA Western NY Healthcare System-Buffalo is the new president of the Association for Research in Vision and Ophthalmology (ARVO). He succeeds Claude F. Burgoyne, MD, FARVO, (Devers Eye Institute) whose one-year term ended in May following the ARVO Annual Meeting.

24-Apr-2018 2:05 PM EDT
Vision Scientists Discover New Eye Treatment for Seasonal Allergies
Association for Research in Vision and Ophthalmology (ARVO)

A recent study shows that a new eye drop may be a potentially effective treatment for seasonal eye allergies, a condition affecting millions of people worldwide. The findings will be presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3

24-Apr-2018 3:25 PM EDT
Vision Studies Offer New Options for Eye Cancer Diagnosis and Treatment
Association for Research in Vision and Ophthalmology (ARVO)

The findings of two new studies may help advance the diagnosis and treatment of eye cancers. The research is being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

24-Apr-2018 2:05 PM EDT
Scientists Discover New Ways to Diagnose and Detect Progression of Glaucoma
Association for Research in Vision and Ophthalmology (ARVO)

Two new research studies demonstrate that imaging technologies can help to diagnose and detect the progression of glaucoma, one of the leading causes of blindness in the U.S. When diagnosed early, vision loss from glaucoma can be slowed or prevented. The two studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

24-Apr-2018 3:40 PM EDT
Researchers Share Latest High-Tech Advances in Vision Research
Association for Research in Vision and Ophthalmology (ARVO)

Researchers from around the world are sharing the latest high-tech advances in research to treat, diagnose and prevent diseases causing vision loss. The new findings demonstrate the impact of technology on vision and on vision science. The five studies will be presented in a news conference — virtually and onsite — at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, on Tuesday, May 1 at 9am.

24-Apr-2018 3:15 PM EDT
Cutting-Edge Research May Help Prevent and Improve Nearsightedness
Association for Research in Vision and Ophthalmology (ARVO)

In a new study, vision researchers found that certain types of lightbulbs and reading at different times of the day may contribute to nearsightedness, a condition clinically referred to as myopia. In another study, scientists found that a common food flavoring may offer new treatment options for reducing nearsightedness. The findings from the three new studies are being presented at the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

24-Apr-2018 3:05 PM EDT
Studies Highlight Potential New Approaches to Treating Vision Conditions
Association for Research in Vision and Ophthalmology (ARVO)

Three new studies demonstrate research findings that could offer novel treatments for vision and eye conditions. The studies will be presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, from Sunday, April 29 – Thursday, May 3.

24-Apr-2018 3:50 PM EDT
New Genetic Research Shows Potential Future Approaches to Vision Care
Association for Research in Vision and Ophthalmology (ARVO)

Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

Released: 9-Apr-2018 9:05 AM EDT
Latest Advances in Eye and Vision Research Featured at ARVO 2018 Annual Meeting
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries. The five-day meeting will feature more than 6,000 poster and paper presentations of cutting-edge eye and vision research, offering an early glimpse into the latest advances in potential treatments for eye disease and blindness — often years ahead of their introduction to clinical practice.

Released: 13-Mar-2018 11:05 AM EDT
International Conference to Bring Together World Leaders in Eye Cancer
Association for Research in Vision and Ophthalmology (ARVO)

The most recent basic and clinical research developments related to the diagnosis and treatment of eye cancer will be the focus of a scientific meeting convened by the Association for Research in Vision and Ophthalmology (ARV0) in partnership with the Champalimaud Foundation. The Ocular Oncogenesis and Oncology Conference will be held July 18 – 21 at the Champalimaud Centre for the Unknown, a state-of-the-art medical and research facility located in Lisbon, Portugal

Released: 6-Feb-2018 5:05 PM EST
Leaders in Vision Science Highlight Benefits of Federally-Funded Research
Association for Research in Vision and Ophthalmology (ARVO)

Leading vision scientists from the U.S. and around the world will gather in Washington, DC on Feb. 9 to discuss federal research funding with members of Congress. The researchers will share examples of how investing taxpayer dollars into basic science has resulted in cost savings for patients and for the Medicare program overall.

1-Dec-2017 12:05 PM EST
New Study Finds Federally-Funded Technology Saved Medicare $9 Billion
Association for Research in Vision and Ophthalmology (ARVO)

A new study quantifying a 21-fold return on investment suggests an efficient — and non-partisan — method to cut healthcare spending is to invest in basic research. The paper tracks how a new technology aids doctors in reducing the number of unnecessary drug injections used to treat a blinding condition called wet age-related macular degeneration (AMD)


Showing results

150 of 223

close
0.24585